SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,197,000 | -43.4% | 55,727 | +14.2% | 0.36% | -34.8% |
| Q2 2019 | $7,418,000 | +23.7% | 48,819 | -3.0% | 0.55% | +28.2% |
| Q1 2019 | $5,997,000 | +12.5% | 50,312 | +3.0% | 0.43% | -2.5% |
| Q4 2018 | $5,333,000 | -54.2% | 48,870 | -32.1% | 0.44% | -29.5% |
| Q3 2018 | $11,632,000 | -41.7% | 72,018 | -52.3% | 0.63% | -42.8% |
| Q2 2018 | $19,942,000 | -17.3% | 150,872 | -53.6% | 1.10% | -22.1% |
| Q1 2018 | $24,106,000 | -38.4% | 325,356 | -53.7% | 1.41% | -38.8% |
| Q4 2017 | $39,139,000 | +20.4% | 703,424 | -1.8% | 2.30% | +12.5% |
| Q3 2017 | $32,501,000 | +62.9% | 716,516 | +21.1% | 2.05% | +58.4% |
| Q2 2017 | $19,952,000 | +19.8% | 591,869 | +5.2% | 1.29% | +26.8% |
| Q1 2017 | $16,651,000 | +91.8% | 562,522 | +77.8% | 1.02% | +73.9% |
| Q4 2016 | $8,681,000 | – | 316,463 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |